|
EP3341007B1
(en)
|
2015-08-28 |
2020-12-23 |
Cornell University |
Malt1 inhibitors and uses thereof
|
|
CN108473499B
(zh)
*
|
2015-11-13 |
2021-07-23 |
诺华股份有限公司 |
新颖的吡唑并嘧啶衍生物
|
|
CN109790143A
(zh)
|
2016-05-10 |
2019-05-21 |
C4医药公司 |
用于靶蛋白降解的胺连接的c3-戊二酰亚胺降解决定子体
|
|
WO2017197046A1
(en)
|
2016-05-10 |
2017-11-16 |
C4 Therapeutics, Inc. |
C3-carbon linked glutarimide degronimers for target protein degradation
|
|
EP4483875A3
(en)
|
2016-05-10 |
2025-04-02 |
C4 Therapeutics, Inc. |
Spirocyclic degronimers for target protein degradation
|
|
EP4491236A3
(en)
|
2016-05-10 |
2025-04-02 |
C4 Therapeutics, Inc. |
Heterocyclic degronimers for target protein degradation
|
|
WO2018165385A1
(en)
|
2017-03-08 |
2018-09-13 |
Cornell University |
Inhibitors of malt1 and uses thereof
|
|
WO2018237026A1
(en)
|
2017-06-20 |
2018-12-27 |
C4 Therapeutics, Inc. |
N/o-linked degrons and degronimers for protein degradation
|
|
WO2019043214A1
(en)
|
2017-09-04 |
2019-03-07 |
F. Hoffmann-La Roche Ag |
glutarimide
|
|
WO2019043208A1
(en)
|
2017-09-04 |
2019-03-07 |
F. Hoffmann-La Roche Ag |
DIHYDROQUINOLINONES
|
|
EP3679027A1
(en)
|
2017-09-04 |
2020-07-15 |
C4 Therapeutics, Inc. |
Dihydrobenzimidazolones
|
|
CN111372585A
(zh)
|
2017-11-16 |
2020-07-03 |
C4医药公司 |
用于靶蛋白降解的降解剂和降解决定子
|
|
EP3731848A4
(en)
|
2017-12-28 |
2021-12-15 |
The General Hospital Corporation |
TARGETING OF THE CBM-SIGNALOSOME COMPLEX FOR INDUCING REGULATORY T-CELLS TO CITIZE INFLAMMATION OF THE TUMOR MICRO-ENVIRONMENT
|
|
JP2021519337A
(ja)
|
2018-03-26 |
2021-08-10 |
シー４ セラピューティクス， インコーポレイテッド |
Ｉｋａｒｏｓの分解のためのセレブロン結合剤
|
|
EP3904350B1
(en)
|
2018-04-12 |
2023-08-23 |
Bayer Aktiengesellschaft |
N-(cyclopropylmethyl)-5-(methylsulfonyl)-n-{1-[1-(pyrimidin-2-yl)-1h-1,2,4-triazol-5-yl]ethyl}benzamide derivatives and the corresponding pyridine-carboxamide derivatives as pesticides
|
|
CN119751456A
(zh)
|
2018-04-16 |
2025-04-04 |
C4医药公司 |
螺环化合物
|
|
MY206796A
(en)
|
2018-04-23 |
2025-01-08 |
Celgene Corp |
Substituted 4-aminoisoindoline-1,3-dione compounds and their use for treating lymphoma
|
|
UA127065C2
(uk)
|
2018-04-25 |
2023-03-29 |
Баєр Акціенгезельшафт |
Нові гетероарил-триазольні та гетероарил-тетразольні сполуки як пестициди
|
|
EP3578561A1
(en)
|
2018-06-04 |
2019-12-11 |
F. Hoffmann-La Roche AG |
Spiro compounds
|
|
CN110615779B
(zh)
*
|
2018-06-20 |
2023-03-24 |
上海科技大学 |
制备来那度胺衍生物的方法
|
|
MY209902A
(en)
*
|
2018-11-28 |
2025-08-09 |
Takeda Pharmaceuticals Co |
Heterocyclic compound
|
|
WO2020132561A1
(en)
|
2018-12-20 |
2020-06-25 |
C4 Therapeutics, Inc. |
Targeted protein degradation
|
|
KR20210141554A
(ko)
|
2019-03-21 |
2021-11-23 |
코디악 바이오사이언시즈, 인크. |
세포외 소포 접합체 및 이의 용도
|
|
WO2020191369A1
(en)
|
2019-03-21 |
2020-09-24 |
Codiak Biosciences, Inc. |
Process for preparing extracellular vesicles
|
|
CA3143508A1
(en)
*
|
2019-06-24 |
2020-12-30 |
Dana-Farber Cancer Institute, Inc. |
Hck degraders and uses thereof
|
|
MX2022000954A
(es)
|
2019-07-23 |
2022-02-14 |
Bayer Ag |
Novedosos compuestos de heteroaril-triazol como plaguicidas.
|
|
TW202128664A
(zh)
|
2019-10-09 |
2021-08-01 |
德商拜耳廠股份有限公司 |
作為除害劑之新穎雜芳基三唑化合物
|
|
CA3162364A1
(en)
*
|
2019-12-20 |
2021-06-24 |
Gesine Kerstin Veits |
Protein tyrosine phosphatase degraders and methods of use thereof
|
|
PH12022551523A1
(en)
*
|
2019-12-27 |
2024-01-29 |
SchraDinger Inc |
Cyclic compounds and methods of using same
|
|
US20230312639A1
(en)
*
|
2020-04-23 |
2023-10-05 |
University Of Iowa Research Foundation |
Gper proteolytic targeting chimeras
|
|
WO2021237100A1
(en)
|
2020-05-21 |
2021-11-25 |
Codiak Biosciences, Inc. |
Methods of targeting extracellular vesicles to lung
|
|
WO2021241611A1
(ja)
|
2020-05-27 |
2021-12-02 |
武田薬品工業株式会社 |
複素環化合物の製造方法
|
|
JP2023530937A
(ja)
*
|
2020-06-17 |
2023-07-20 |
ダナ－ファーバー キャンサー インスティテュート，インコーポレイテッド |
Ｅ３－リガーゼ系の共動員を介した標的化された異常なα－シヌクレイン種ならびに誘導されたユビキチン化およびプロテアソームクリアランス
|
|
WO2021262969A1
(en)
|
2020-06-24 |
2021-12-30 |
The General Hospital Corporation |
Materials and methods of treating cancer
|
|
US20240241020A1
(en)
|
2020-09-23 |
2024-07-18 |
Lonza Sales Ag |
Process for preparing extracellular vesicles
|
|
JP2023549835A
(ja)
*
|
2020-11-12 |
2023-11-29 |
モノプテロス セラピューティクス，インコーポレーテッド |
がんを治療する材料及び方法
|
|
EP4277901A1
(en)
|
2021-01-13 |
2023-11-22 |
Monte Rosa Therapeutics, Inc. |
Isoindolinone compounds
|
|
US12123053B2
(en)
|
2021-01-29 |
2024-10-22 |
Eurofins Discoverx Corporation |
Molecular glue screening assays and methods for practicing same
|
|
MX2024008008A
(es)
|
2021-12-30 |
2024-07-12 |
Shanghai Hansoh Biomedical Co Ltd |
Derivado triciclico inhibidor, metodo de preparacion de este y aplicacion de este.
|
|
US20250092066A1
(en)
*
|
2022-01-18 |
2025-03-20 |
Aurigene Oncology Limited |
Substituted bicyclic heterocycles as malt-1 inhibitors
|
|
WO2023143249A1
(zh)
*
|
2022-01-28 |
2023-08-03 |
上海齐鲁制药研究中心有限公司 |
靶向malt1的蛋白降解化合物
|
|
JPWO2023149450A1
(enExample)
|
2022-02-02 |
2023-08-10 |
|
|
|
KR20240163083A
(ko)
*
|
2022-02-25 |
2024-11-18 |
테지드 테라퓨틱스 인코포레이티드 |
Malt1의 protac
|
|
CN119325475A
(zh)
|
2022-06-06 |
2025-01-17 |
C4医药公司 |
双环取代的戊二酰亚胺cereblon结合剂
|